DK529879A - Galeniske praeparater indehldende ergotalkaloider - Google Patents

Galeniske praeparater indehldende ergotalkaloider

Info

Publication number
DK529879A
DK529879A DK529879A DK529879A DK529879A DK 529879 A DK529879 A DK 529879A DK 529879 A DK529879 A DK 529879A DK 529879 A DK529879 A DK 529879A DK 529879 A DK529879 A DK 529879A
Authority
DK
Denmark
Prior art keywords
ergotal
caloids
preparations containing
galenic preparations
galenic
Prior art date
Application number
DK529879A
Other languages
English (en)
Other versions
DK154607B (da
DK154607C (da
Inventor
J Franz
L Patt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK529879A publication Critical patent/DK529879A/da
Publication of DK154607B publication Critical patent/DK154607B/da
Application granted granted Critical
Publication of DK154607C publication Critical patent/DK154607C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK529879A 1978-12-21 1979-12-12 Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider DK154607C (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH1302178 1978-12-21
CH1301978 1978-12-21
CH1301978 1978-12-21
CH1302178 1978-12-21
CH56679 1979-01-19
CH56779 1979-01-19
CH56779 1979-01-19
CH56679 1979-01-19

Publications (3)

Publication Number Publication Date
DK529879A true DK529879A (da) 1980-06-22
DK154607B DK154607B (da) 1988-12-05
DK154607C DK154607C (da) 1989-06-05

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK529879A DK154607C (da) 1978-12-21 1979-12-12 Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider

Country Status (23)

Country Link
AT (1) AT372279B (da)
AU (1) AU534051B2 (da)
CA (1) CA1139222A (da)
CH (1) CH642259A5 (da)
CY (1) CY1330A (da)
DE (1) DE2950154A1 (da)
DK (1) DK154607C (da)
FI (1) FI793888A7 (da)
FR (1) FR2444463A1 (da)
GB (1) GB2038181B (da)
HK (1) HK37986A (da)
HU (1) HU182577B (da)
IE (1) IE49323B1 (da)
IL (1) IL59003A (da)
IT (1) IT1164029B (da)
KE (1) KE3617D (da)
MY (1) MY8500129A (da)
NL (1) NL187229C (da)
NZ (1) NZ192457A (da)
PH (1) PH25178A (da)
PT (1) PT70614A (da)
SE (1) SE442265B (da)
WO (1) WO1980001242A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (en) * 1981-04-27 1985-07-24 Aktiebolaget Hässle New pharmaceutical preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Also Published As

Publication number Publication date
NL187229C (nl) 1991-07-16
IT1164029B (it) 1987-04-08
CY1330A (en) 1986-06-27
IT7951153A0 (it) 1979-12-20
HU182577B (en) 1984-02-28
GB2038181A (en) 1980-07-23
FR2444463B1 (da) 1983-02-25
IE792471L (en) 1980-06-21
NZ192457A (en) 1983-06-17
AT372279B (de) 1983-09-26
MY8500129A (en) 1985-12-31
SE442265B (sv) 1985-12-16
DE2950154C2 (da) 1989-05-11
DE2950154A1 (de) 1980-07-10
AU5403179A (en) 1980-06-26
DK154607B (da) 1988-12-05
SE7910227L (sv) 1980-06-22
FI793888A7 (fi) 1981-01-01
IE49323B1 (en) 1985-09-18
AU534051B2 (en) 1984-01-05
FR2444463A1 (fr) 1980-07-18
WO1980001242A1 (fr) 1980-06-26
PH25178A (en) 1991-03-27
CA1139222A (en) 1983-01-11
CH642259A5 (de) 1984-04-13
PT70614A (fr) 1980-01-01
GB2038181B (en) 1983-05-11
ATA803679A (de) 1983-02-15
HK37986A (en) 1986-05-30
KE3617D (en) 1986-04-18
NL7909105A (nl) 1980-06-24
IL59003A (en) 1982-12-31
DK154607C (da) 1989-06-05

Similar Documents

Publication Publication Date Title
AT367604B (de) Insektizidpraeparate
NO149531C (no) Administreringssett
AT369262B (de) Shampoozusammensetzung
IT1123862B (it) Complesso di cateterismo
FI793759A7 (fi) Stol
DK348079A (da) Administrationsform
FI793389A7 (fi) Framstaellning av ett antihemofilifaktorpreparat av maenniskoblodplasma
BE875773A (nl) 2'deoxy-5-(halogeenvinyl)-uridines
DK107480A (da) Kosmetisk praeparat
ATE202T1 (de) 2-cycloalkyl-pyrimidin(5)
DK425479A (da) Blegepraeparater
IT1218878B (it) Preparazione aerosolica
FI65844B (fi) Virvelluftsrenar- och dimeliminatorenhet foer en gasturbinmotor i marint bruk
LU81342A1 (fr) Preparations anti-caries
DK99179A (da) Mejetaersker
FI791277A7 (fi) Slaglisthaollare foer rotorn i en slagkvarn
DK39079A (da) Stabilt praeparat
DK384379A (da) Etmidatholdige praeparater
FI791442A7 (fi) Upphaengningskorrektor anvaendbar i laosta slingavstaemningssystem
FI793049A7 (fi) Foerfarande foer framstaellning av natriumamoxicillin-preparat
FI793888A7 (fi) Galeenisia seoksia.
DK351379A (da) Pesticidt virksomme praeparater
BE880458A (nl) Verbeterde fluspirileen-bevattende preparaten
FI790648A7 (fi) Medicinskt anvaendbar stol speciellt tandlaekarstol
NL7902103A (nl) Emulgeerbare preparaten.

Legal Events

Date Code Title Description
PBP Patent lapsed